Why new precision oncology treatments benefit patients of some ancestries more than others
Nearly half of all new cancer drugs approved by the U.S. Food and Drug Administration (FDA) over the past quarter-century ...
scientific-computing19h
Data ontologies and efficiency of process development
“Time-to-market is money,” says Lukas Kürten, Digital Innovation Manager at CPI. “If you’ve got a process that works, you’ve got to throw it into manufacturing, because you’ve got to milk your patent ...